Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer

Clinical Biochemistry

Volumn 41, Issue 14-15, 2008, Pages 1224-1236

  Petrova, Darinka Todorova ^a,b   Asif, Abdul R ^b   Armstrong, Victor W ^b   Dimova, Ivanka ^a   Toshev, Svetoslav ^c   Yaramov, Nikolay ^c   Oellerich, Michael ^b   Toncheva, Draga ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

ANXA5; CLIC1; colorectal cancer; Proteomics; TPD52

Indexed keywords

BIOLOGICAL MARKER; CHLORIDE INTRACELLULAR CHANNEL PROTEIN 1; PROTEIN DERIVATIVE; TUMOR PROTEIN D52; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DENSITOMETRY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

AGED; AGED, 80 AND OVER; CHLORIDE CHANNELS; COLORECTAL NEOPLASMS; DEMOGRAPHY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEOPLASM PROTEINS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 55649084135     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.07.012     Document Type: Article

References (35)

1. Friedman D.B., Hill S., Keller J.W., Merchant N.B., Levy S.E., Coffey R.J., and Caprioli R.M. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 793-811
2. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
3. Ilyas M., Straub J., Tomlinson I.P., and Bodmer W.F. Genetic pathways in colorectal and other cancers. Eur. J. Cancer 35 (1999) 1986-2002
4. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3 (2003) 453-458
5. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
6. Alfonso P., Nus{cyrillic}ez A., Madoz-Gurpide J., Lombardia L., Sanchez L., and Casal J.I. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 5 (2005) 2602-2611
7. Bi X., Lin Q., Foo T.W., et al. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol. Cell Proteomics 5 (2006) 1119-1130
8. Polley A.C., Mulholland F., Pin C., et al. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 66 (2006) 6553-6562
9. Stulík J., Hernychová L., Porkertová S., et al. Proteome study of colorectal carcinogenesis. Electrophoresis 22 (2001) 3019-3025
10. Tomonaga T., Matsushita K., Yamaguchi S., et al. Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin. Cancer Res. 10 (2004) 2007-2014
11. Xing X., Lai M., Gartner W., et al. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin. Proteomics 6 (2006) 2916-2923
12. Compton C.C., and Greene F.L. The staging of colorectal cancer: 2004 and beyond. CA Cancer J. Clin. 54 (2004) 295-308
13. Raichev R. Morphological diagnostics of the tumors. Sofia; Medicine and Physical Culture Press; 1983 [Book in Bulgarian].
14. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
15. Gorg A., Obermaier C., Boguth G., et al. The current state of two-dimensional electrophoresis with immobilized ph gradients. Electrophoresis 21 (2000) 1037-1053
16. Blum H., Beier H., and Gross H.J. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8 (1987) 93-99
17. Luhn S., Berth M., Hecker M., and Bernhardt J. Using standard positions and image fusion to create proteome maps from collections of two-dimensional gel electrophoresis images. Proteomics 3 (2003) 1117-1127
18. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
19. Asif A.R., Oellerich M., Amstrong V.W., Riemenschneider B., Monod M., and Reichard U. Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. J. Proteome Res. 5 (2006) 954-962
20. Asif A.R., Armstrong V.W., Voland A., Wieland E., Oellerich M., and Shipkova M. Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. Biochimie 89 (2007) 393-402
21. Balleine R.L., Fejzo M.S., Sathasivam P., Basset P., and Clarke C.L. Byrne JA,The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma. Genes Chromosomes Cancer 29 (2000) 48-57
22. Lewis J.D., Payton L.A., Whitford J.G., et al. Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52. Mol. Cancer Res. 5 (2007) 133-144
23. Chen C.D., Wang C.S., Huang Y.H., et al. Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 7 (2007) 155-167
24. Wulfkuhle J.D., Sgroi D.C., Krutzsch H., et al. Proteomics of human breast ductal carcinoma in situ. Cancer Res. 62 (2002) 6740-6749
25. Huang J.S., Chao C.C., Su T.L., et al. Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 315 (2004) 950-958
26. Byrne J.A., Balleine R.L., Schoenberg Fejzo M., et al. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. Int. J. Cancer 117 (2005) 1049-1054
27. Rubin M.A., Varambally S., Beroukhim R., et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res. 64 (2004) 3814-3822
28. Wang R., Xu J., Saramaki O., et al. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res. 64 (2004) 1589-1594
29. Scanlan M.J., Gout I., Gordon C.M., et al. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun. 1 (2001) 4
30. Siegel P.M., and Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3 (2003) 807-821
31. Derynck R., Akhurst R.J., and Balmain A. TGF-h signaling in tumor suppression and cancer progression. Nat. Genet. 29 (2001) 117-129
32. Chen T., Jackson C., Costello B., et al. An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. Int. J. Cancer 112 (2004) 420-425
33. Bian Y., Caldes T., Wijnen J., et al. TGFBR1*6A may contribute to hereditary colorectal cancer. J. Clin. Oncol. 23 (2005) 3074-3078
34. Jonson T., Albrechtsson E., Axelson J., et al. Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. Int. J. Oncol. 19 (2001) 71-81
35. Kim I.Y., Ahn H.J., Zelner D.J., et al. type II receptors correlates with tumor grade in human prostate cancer tissues. Clin. Cancer Res. 2 (1996) 1255-1261